Kuros Biosciences AG (SWX: KURN)

Switzerland flag Switzerland · Delayed Price · Currency is CHF
16.56
-0.50 (-2.93%)
Sep 4, 2024, 1:56 PM CET
804.92%
Market Cap 636.38M
Revenue (ttm) 52.54M
Net Income (ttm) -8.89M
Shares Out 37.30M
EPS (ttm) -0.31
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 105,454
Open 16.78
Previous Close 17.06
Day's Range 16.24 - 17.00
52-Week Range 1.85 - 17.52
Beta 0.86
Analysts n/a
Price Target n/a
Earnings Date Nov 7, 2024

About Kuros Biosciences AG

Kuros Biosciences AG, a biopharmaceutical company, engages in the commercialization and development for tissue repair and bone regeneration in the United States, the European Union, and internationally. It operates through three segments: Medical Devices, Pharmaceuticals, and Legacy Portfolio. The company offers MagnetOs Granules, an original advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold use to fill bony voids for a predictable fusion; MagnetOs Easypack Putty, a ready-to-use mold ... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2016
Employees 106
Stock Exchange SIX Swiss Exchange
Ticker Symbol KURN
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.